CardsJC: EMPEROR-Preserved Trial - Cardionerds Twitter Journal Club
Entresto | C96H120N12Na6O21 | CID 71449007 - PubChem
LCZ696 (Valsarta + sacubitril) | C48H57N6Na3O9 | CID 24755604 - PubChem
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition | Circulation
Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure | NEJM
Sacubitril | New Drug Approvals
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial - The Lancet
Bio <-> Chem: Back-story on Novartis LCZ696 database links
LCZ696 (Valsarta + sacubitril) | C48H57N6Na3O9 | CID 24755604 - PubChem
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure | NEJM
File:Valsartan.svg - Wikipedia
PharmaWiki - Sacubitril
Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy | Circulation: Heart Failure
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial - The Lancet
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial - The Lancet
VALSARTAN
Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy | Circulation: Heart Failure
Is Entresto good for the brain? - Abstract - Europe PMC
Entresto | C96H120N12Na6O21 | CID 71449007 - PubChem
Bio <-> Chem: Back-story on Novartis LCZ696 database links
Sacubitril/valsartan - Wikipedia
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition | Circulation
Heart failure with preserved ejection fraction: emerging drug strategies. - Abstract - Europe PMC
